Richmond, Virginia

Richmond has emerged as a premier global life sciences hub, distinguished by its specialized leadership in advanced pharmaceutical manufacturing and biotechnology innovation.

It hosts the VA Bio+Tech Park, a 34-acre urban research campus housing nearly 70 life science companies, including the Medicines for All Institute.

The region is internationally recognized for its "end-to-end" drug substance production capabilities, fueled by the Alliance for Building Better Medicine, which aims to secure the domestic and global medicine supply chain.

Powering the sector's talent pipeline is Virginia Commonwealth University (VCU), a top 50 public research university featuring the nation's first PhD program in pharmaceutical engineering.

Richmond’s healthcare innovation is further anchored by the VCU Medical Center, a Level 1 trauma center that bridges the gap between clinical trials and patient care.

The city's medical device and medtech sectors thrive through specialized incubators like Activation Capital, which provide essential wet lab space and early-stage venture support.

Strategic investments in bioinformatics and genetic testing continue to attract global life sciences establishments seeking a lower-cost, high-innovation environment.

With record-breaking venture capital investment and a central Mid-Atlantic location, Richmond offers unparalleled access to federal regulatory agencies and international markets.

Consequently, the "RVA" life sciences cluster has become a vital destination for companies specializing in translational medicine, small molecule API development and sustainable healthcare solutions.